Cvs Health
What Cvs Health is up to now
Pushing AI into every consumer touchpoint at once — Aetna claims >20% faster, pharmacy dispensing, call centers, an explicit 'AI front door to health care' ambition (07-16) — with a virtual-MH-AI + GLP-1 integrated-care push (05-29) as the payer bloc's most direct MH signal. Controversy layer came back thin — a coverage gap, not confirmed quiet.
as of 2026-07-28
Sphere us
Pocket
Health
Payer-PBM-pharmacy (+Aetna/Caremark); debt-laden and constrained.
The metrics
- Posture med
- retrenching 2 src →
- Capital · available high
- ~$9.5B cash + ~$2.3B short-term inv (~$34.7B total investments/float) against ~$78-80B total debt — the most leveraged payer here 1 src →
- Capital · operating high
- ~$402B FY25 revenue (~$408B TTM); operating cash flow ~$10.6B FY25 / ~$10.3B TTM 1 src →
- Capital · deployed high
- ~$2.8B capex + ~$0.4B small acquisitions FY25; buybacks essentially halted (~$158M) 1 src →
- Capital · in high
- inflows — ~$402B FY25 revenue: Aetna premiums + Caremark PBM + CVS Pharmacy retail 1 src →
- Capital · out high
- outflows — medical + pharmacy cost of goods dominate; then ~$3.4B dividends, ~$0.4B M&A, minimal (~$0.16B) buybacks, plus debt service on ~$78-80B 1 src →
- Optionality high
- constrained — MLR caps the Aetna insurance core AND ~$78-80B debt + a near-frozen buyback (cash to deleverage) leaves little dry powder; the freest lever is retail/PBM cost-cutting, not … 1 src →
- Gravity med
- GROSS ~$402B/yr routed — Caremark PBM 75M+ members, ~9,100-9,600 pharmacies (~1/5 of US scripts), Aetna medical members; a payer-PBM-pharmacy triple choke-point. 2 src →
Projects & threads
No live threads tagged to this actor this week.
Vocabulary